Archives
-
Lypressin acetate: Applied Research Workflows
2026-09-23
Lypressin acetate supports coordinated studies of vasopressin receptor signaling, antidiuretic biology, and vasoconstriction research in one peptide framework. This guide translates its receptor profile and activity specifications into practical assay workflows, comparative experiments, troubleshooting steps, and a carefully bounded antiviral research strategy.
-
Metformin Attenuates Vocal Fold Fibrosis via AMPK
2026-09-22
The reference study shows that metformin reduced collagen deposition and profibrotic marker expression in rabbit vocal-fold injury and TGF-β1-stimulated fibroblast models. Its central contribution is linking these antifibrotic effects to AMPK activation and suppression of the TGF-β/Smad axis, while also defining a practical framework for mechanistic validation.
-
Bleomycin Sulfate: Reading Cell Responses
2026-09-22
Bleomycin Sulfate is more than a DNA damage reagent: it can reveal how proliferation arrest, cell death, and delayed injury diverge in experimental systems. This guide combines mechanism, assay design, and cross-domain interpretation for oncology and pulmonary fibrosis research.
-
BRD4, TXNIP, and Ferroptosis Sensitivity
2026-09-21
The 2025 Cell Death and Disease study identifies a previously underappreciated BRD4–TXNIP–histone H4 UFMylation pathway that governs c-MYC chromatin activity and ferroptosis sensitivity. Its findings suggest that BET inhibition can place solid-tumor cells into a quiescent, drug-tolerant state while creating a vulnerability that may be exploitable with ferroptosis-inducing strategies.
-
Macrophage-Targeted STING Editing in Pulmonary Fibrosis
2026-09-21
Wang et al. developed an inhalable phosphatidylserine-decorated lipid nanoparticle that preferentially delivers CRISPR-Cas9 mRNA to pathogenic alveolar macrophages for in vivo Sting1 editing. The approach reduced STING-associated inflammatory and fibrotic responses in mice, illustrating how cell-selective pulmonary delivery can address a major barrier in pulmonary fibrosis research.
-
Microbiota–AhR Signaling in Ulcerative Colitis Repair
2026-09-20
Li et al. identify a microbiota–tryptophan metabolism–AhR–intestinal stem cell axis through which Huangqin decoction supports epithelial repair in dextran sulfate sodium-induced colitis. The study combines metagenomics, metabolite profiling, receptor-pathway analysis, and pharmacological or antibiotic perturbation to connect microbial metabolites with intestinal stem cell differentiation and barrier recovery.
-
Polymyxin B: A Cleaner Readout for Immune Assays
2026-09-19
Polymyxin B sulfate is more than a membrane-active antibiotic: it can expose confounding interactions between bacterial killing, innate signaling, and microbiome-dependent phenotypes. This guide develops a rigorous assay framework grounded in infection biology and a recent allergic-rhinitis rat study.
-
Spiroplasma Entry into Drosophila S2 Cells
2026-09-18
Wei et al. established a Drosophila Schneider 2 cell model to define how Spiroplasma eriocheiris enters and proliferates within invertebrate-derived cells. Their results identify clathrin-mediated endocytosis and macropinocytosis as the principal entry routes, while linking infection to actin, microtubules, PKC signaling, oxidative stress, and cell death.
-
HotStart 2X Green qPCR Master Mix for URSA
2026-09-18
Translate miRNA and IRAK1 pathway discoveries into specific, reproducible SYBR Green assays for recurrent pregnancy-loss research. This workflow combines hot-start control, melt-curve verification, and disciplined normalization for gene expression analysis, RNA-seq validation, and nucleic acid quantification.
-
BIIE 0246 in Receptor-Resolved NPY Research
2026-09-17
BIIE 0246 is a selective neuropeptide Y Y2 receptor antagonist for separating presynaptic Y2R signaling from the Y1R pathway implicated in adipose-neural cardiac arrhythmia. This article translates recent coculture findings into receptor-resolved assay strategies while defining the compound’s applications and limitations.
-
nor-NOHA Acetate: Arginase Research Workflow
2026-09-17
nor-NOHA acetate provides a reversible way to perturb arginine partitioning between arginase and nitric oxide synthase in cancer, endothelial, and immunometabolism assays. This workflow connects enzyme inhibition with apoptosis, invasion, endothelial signaling, and hypothesis-testing studies of AML immune escape.
-
CGRP/SP–Piezo2 Signaling in Trigeminal Neuralgia
2026-09-16
Liao et al. identify a Ca2+-dependent CGRP/SP–Piezo2 feedback loop linking trigeminal root compression, neuroinflammation, and mechanical allodynia. Their rat and cellular experiments position the trigeminal ganglion–Merkel cell axis as a mechanistic bridge between ATP signaling, PKC, ERK1/2, p38 MAPK, and pain-related mechanotransduction.
-
Isorhamnetin Oocyte Stress Research Workflow
2026-09-16
Isorhamnetin provides a mechanism-oriented workflow for connecting oocyte maturation with oxidative stress, apoptosis, endoplasmic reticulum stress, and PI3K/Akt signaling. Its dose-response design and multi-endpoint readout make it useful for distinguishing genuine cytoprotection from nonspecific vehicle or viability effects.
-
Bleomycin Sulfate: From DNA Damage to Fibrosis
2026-09-15
Bleomycin Sulfate is more than a cytotoxic reagent: it is a controllable perturbation for connecting metal-dependent DNA strand breaks with cell fate, inflammatory signaling, and fibrotic remodeling. This article offers translational guidance for oncology and pulmonary fibrosis research, incorporating recent evidence on the miR-4769-3p/USP18/VDAC2 axis in systemic sclerosis.
-
SB525334 Workflow for TGF-beta1 Signaling Studies
2026-09-15
SB525334 provides a selective ALK5-centered way to test whether TGF-beta1 signaling drives fibrosis, renal injury, or wound-repair phenotypes. This workflow connects receptor inhibition with Smad2/3 phosphorylation, tissue markers, and functional outcomes while separating reference-study evidence from practical assay recommendations.